Honey Adulteration: CCPA Asks FSSAI To Take Appropriate Action

New Delhi : The Central Consumer Protection Authority (CCPA) has asked food regulator FSSAI to take appropriate action against adulteration reported in certain honey brands and also extended cooperation for investigation for taking class action.

Last week, environment watchdog CSE claimed that honey sold by several major brands in India has been found to be adulterated with sugar syrup. However, the companies have refuted the claims. In an official statement, the consumer affairs ministry expressed concern over the reported adulteration of honey.

“It has been reported to the Department that most of the honey brands sold in the market are adulterated with sugar syrup. This is a serious matter as it will compromise our health in the troubled times of COVID-19 and add to the risk of COVID-19,” the ministry said.

The Department of Consumer Affairs asked CCPA to look into matter, it added. “The CCPA, in accordance with section 19(2) of the Consumer Protection Act 2019, after preliminary examination, has referred the matter to the FSSAI, the food regulator, to take appropriate action in the matter… “…and has offered to extend cooperation in investigation of the matter for taking class action as envisaged in section 10 of the Act,” the statement said.

The Centre for Science and Environment (CSE) food researchers selected 13 top as well as smaller brands of processed and raw honey being sold in India to check their purity. It was found that 77 per cent of the samples were adulterated with sugar syrup. Out of the 22 samples checked, only five passed all the tests.

“Honey samples from leading brands such as Dabur, Patanjali, Baidyanath, Zandu, Hitkari and Apis Himalaya, all failed the NMR (Nuclear Magnetic Resonance) test,” the study said. Emami (Zandu), Dabur, Patanjali Ayurveda and Apis Himalaya have refuted the claims made by CSE. A day after the CSE study was released, the Food Safety and Standards Authority of India (FSSAI) sought details of the tests, even as it raised questions over why its prescribed tests were not conducted.

The FSSAI had stated that the CSE found the adulterants by using “the non-prescription” Trace Marker for Rice syrup (TMR) test instead of “a more sensitive” Specific Marker for Rice syrup test (SMR). The consumer affairs department further said it takes the consumer issues seriously.

Related Posts

‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

Domestic Medical Device Leaders cry foul against move to do away with Policy Restrictions New Delhi:  The union government mandarins seem to be at it again, diametrically opposed to Prime…

Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India

Best in Class ‘Made in India’ Surgical Robot is proving Best Bet New Delhi: ‘Made in India’ best in class surgical robot SSiMantra is proving godsend for cancer patients in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ayush export declines by 7.4% in first nine months of FY 26

Ayush export declines by 7.4% in first nine months of FY 26

Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

ICMR mandates clinical trials to focus on Indian demography, lifestyle

ICMR mandates clinical trials to focus on Indian demography, lifestyle

India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested

Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested